GSK1070916是可逆的ATP竞争性Aurora B和C抑制剂,IC50分别为3.5 nM和6.5 nM。而对于Aurora A-TPX2复合物的IC50则为490 nM。 GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
GSK1070916
CAS number:942918-07-2 molecular formula:C30H33N7O
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | HY-70044 | AKOS005145558 | GTPL8358 | 3-(4-(4-(2-(3-((DIMETHYLAMINO)METHYL)PHENYL)-1H-PYRROLO(2,3-B)PYRIDIN-4-YL)-1-ETHYL-1H-PYRAZOL-3-YL)PHENYL)-1,1-DIMETHYLUREA | 8VLB51V7HO | NCGC00346648-10 | compound 17k [PMID 20420387] | MFCD22420815 | F17366 | s274 | ||
| CAS number | 942918-07-2 | molecular formula | C30H33N7O |
| molecular weight | 507.63 g/mol | Exact mass | - |
| PSA | 82.100 Ų | logp | 3.9 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





